申请人:Otsuka Pharmaceutical Co., Ltd.
公开号:US05238938A1
公开(公告)日:1993-08-24
The novel indole derivatives and salts thereof represented by the general formula (1) ##STR1## possess, for example, an inhibitory effect against superoxide (O.sub.2.sup.-) released from the macrophage cells of guinea pig by stimulation and an anti-albuminuria activity against Masugi nephritis, and are useful in various clinical fields as an agent for preventing and treating diseases and cases associated with the above superoxide radical, for example, autoimmune diseases (e.g. rheumatism), arteriosclerosis, ischemic disease, ischemic encephalopathia, hepatic insufficiency and renal insufficiency, and also as an agent for preventing and treating nephritis.
通用公式(1)表示的新的吲哚衍生物及其盐具有抑制豚鼠巨噬细胞释放的超氧化物(O.sub.2.sup.-)的作用,例如,对马杉肾炎引起的抗白蛋白尿活性,并且在各种临床领域中作为预防和治疗与上述超氧自由基相关的疾病和情况的药物,例如自身免疫疾病(例如风湿病),动脉硬化,缺血性疾病,缺血性脑病,肝功能不全和肾功能不全,以及作为预防和治疗肾炎的药物。